OSX Stock Overview
Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Osteopore Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.086 |
| 52 Week High | AU$0.30 |
| 52 Week Low | AU$0.085 |
| Beta | 0.55 |
| 1 Month Change | -28.33% |
| 3 Month Change | -42.67% |
| 1 Year Change | -50.86% |
| 3 Year Change | -75.43% |
| 5 Year Change | n/a |
| Change since IPO | -88.14% |
Recent News & Updates
Shareholder Returns
| OSX | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -3.4% | -3.0% | 0.1% |
| 1Y | -50.9% | -0.2% | -8.9% |
Return vs Industry: OSX underperformed the Australian Medical Equipment industry which returned 0.1% over the past year.
Return vs Market: OSX underperformed the Australian Market which returned -9% over the past year.
Price Volatility
| OSX volatility | |
|---|---|
| OSX Average Weekly Movement | 11.4% |
| Medical Equipment Industry Average Movement | 9.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in AU Market | 14.5% |
| 10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: OSX is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: OSX's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Khoon Seng Goh | https://www.osteopore.com |
Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects.
Osteopore Limited Fundamentals Summary
| OSX fundamental statistics | |
|---|---|
| Market Cap | AU$10.66m |
| Earnings (TTM) | -AU$4.20m |
| Revenue (TTM) | AU$1.69m |
6.3x
P/S Ratio-2.5x
P/E RatioIs OSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSX income statement (TTM) | |
|---|---|
| Revenue | AU$1.69m |
| Cost of Revenue | AU$419.10k |
| Gross Profit | AU$1.27m |
| Other Expenses | AU$5.47m |
| Earnings | -AU$4.20m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.034 |
| Gross Margin | 75.24% |
| Net Profit Margin | -247.89% |
| Debt/Equity Ratio | 0% |
How did OSX perform over the long term?
See historical performance and comparison